Who
Annie McGuire
EVP, General Counsel
Company insider
Files Form 4 as: EVP, General Counsel, Veracyte.
In numbers
- Trades disclosed
- 61
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $3.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Feb 2022
- Last trade
- 4 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $92K2,154 at $42.79 | filing |
| 4 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $48K1,100 at $43.67 | filing |
| 4 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $92K2,154 at $42.79 | filing |
| 4 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $48K1,100 at $43.67 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $144K3,215 at $44.88 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $144K3,215 at $44.88 | filing |
| 4 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $69K1,400 at $49.31 | filing |
| 4 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $89K1,776 at $50.12 | filing |
| 4 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $69K1,400 at $49.31 | filing |
| 4 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $89K1,776 at $50.12 | filing |
| 2 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $157K3,292 at $47.80 | filing |
| 2 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $157K3,292 at $47.80 | filing |
| 6 May 2026filed 8 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $194K5,102 at $38.05 | filing |
| 6 May 2026filed 8 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $204K5,102 at $40.00 | filing |
| 6 May 2026filed 8 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $194K5,102 at $38.05 | filing |
| 6 May 2026filed 8 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $204K5,102 at $40.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —32,892 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —26,314 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —32,892 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —26,314 at $0.00 | filing |
News
Veracyte's Decipher Can Help Men Detect Prostate CancerVCYT · finanzen.ch · 23 Oct 2026Phase III Trial Shows Veracyte's Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate CancerVCYT · manilatimes.net · 23 Oct 2026
0 headlines in the last 90 days name Annie McGuire; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.